The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...

We anticipate Dexcom can continue to offer new features, such as lengthening sensor life, shrinking the size and profile of the CGM, making the insertion less painful, and improving accuracy.

Global sensation Nick Jonas has always been open about his health journey, and recently, the singer reflected on being ...

The longer wear time should improve Dexcom’s margins and help it compete with Abbott, RBC Capital Markets analyst Shagun Singh said.

The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

It's the longest-lasting wearable on the market. The G7 15-day sensor builds on the technology and performance of the Dexcom G7 CGM, which has proven to lower A1C and reduce hyper- and hypoglycemia.